References
1. Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM.
The biology of chronic myeloid leukemia. The New England journal of
medicine. 1999;341(3):164-72.
2. Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in
430 patients with chronic myeloid leukaemia seen at a referral centre
over a 16-year period. British journal of haematology. 1997;96(1):111-6.
3. Mohamed SSI, Qasim HM, Mahfouz A, Osman MA, Ahmed AOE, Al-Azewi SH,
et al. Chronic myelogenous leukemia presenting with Morel Lavallée
lesion: A case report of a rare presentation. Clinical case reports.
2022;10(12):e6807.
4. Lakhotia M, Pahadiya HR, Prajapati GR, Choudhary A, Gandhi R.
Spontaneous Soft Tissue Haematomas- A Rare Presentation of Chronic
Myeloid Leukemic (CML). Journal of clinical and diagnostic research :
JCDR. 2015;9(7):Od03-5.
5. Vardiman JW. Chronic Myelogenous Leukemia, BCR-ABL1+. American
Journal of Clinical Pathology. 2009;132(2):250-60.
6. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: a cancer
journal for clinicians. 2017;67(1):7-30.
7. Moloney WC. Radiogenic leukemia revisited. Blood. 1987;70(4):905-8.
8. Baccarani M, Dreyling M. Chronic myeloid leukaemia: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Annals of
oncology : official journal of the European Society for Medical
Oncology. 2010;21 Suppl 5:v165-7.
9. Granatowicz A, Piatek CI, Moschiano E, El-Hemaidi I, Armitage JD,
Akhtari M. An Overview and Update of Chronic Myeloid Leukemia for
Primary Care Physicians. Korean journal of family medicine.
2015;36(5):197-202.
10. Kartthik S, Mandal PK, Abdullah SM. An Unusual Cause of Bleeding in
a Patient with Chronic Myeloid Leukemia Chronic Phase. Case reports in
hematology. 2019;2019:5674193.
11. Solh T, Botsford A, Solh M. Glanzmann’s thrombasthenia:
pathogenesis, diagnosis, and current and emerging treatment options.
Journal of blood medicine. 2015;6:219-27.
12. Mohri H, Tanabe J, Yamazaki E, Yoshida M, Harano H, Matsuzaki M, et
al. Acquired type 2A von Willebrand disease in chronic myelocytic
leukemia. Hematopathology and molecular hematology. 1996;10(3):123-33.
13. Scolaro JA, Chao T, Zamorano DP. The Morel-Lavallée Lesion:
Diagnosis and Management. The Journal of the American Academy of
Orthopaedic Surgeons. 2016;24(10):667-72.
14. Hadley C, Wowkanech C, Eck B, Austin L, Sankar W, Tjoumakaris F.
Morel-Lavallée Lesion: Presenting Etiology of Chronic Myelogenous
Leukemia in an Adolescent Athlete: A Case Report. JBJS case connector.
2016;6(4):e99.
Lists of abbreviation
BCR/ABL1-break point cluster region/ Abelson tyrosine-protein kinase 1
CML-chronic myelogenous leukemia
CT-computed tomography
FISH-fluorescent insitu hybridization
mRNA-messenger ribonucleic acid
P.O-per os.
RT-PCR-reverse transcription polymerase chain reaction
WBC-white blood cell
Declarations
Ethics approval and consent to participate
There are no ethical concerns about this case report.
Consent for publication
Written informed consent was obtained from the patient for publication
of this case report and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of this journal.
Availability of data and materials
All of data and materials for this case report are available from
corresponding author.
Competing interests
We declare that there are no competing interests.
Funding
We received no financial support for this case report.
Authors’ contributions
Dr. Gebeyehu Tessema Azibte -writing, reviewing and editing
Dr. Getnet Yigzaw Mossie-source, writing original draft
Dr. Zekarias Seifu Ayalew-reviewing and editing
Acknowledgments
Not applicable